
GC32703
Asciminib
Also listed as Asciminib (ABL001)
Asciminib (ABL001) (ABL001) is a potent and selective allosteric BCR-ABL1 inhibitor, which inhibits Ba/F3 cells grown with an IC50 of 0·25 nM
ChemicalCAS1492952-76-7MW449.84FormulaC20H18ClF2N5O3
- CAS number
- 1492952-76-7
- Molecular weight
- 449.84
- Formula
- C20H18ClF2N5O3
- Solubility
- DMSO : ≥ 100 mg/mL (222·30 mM)
- InChIKey
- VOVZXURTCKPRDQ-CQSZACIVSA-N
- Catalogue number
- GC32703
- Brand
- GLPBIO
Computed properties PubChem CID 72165228 · XLogP 3 · TPSA 103 Ų · H-bond donors 3
- XLogP
- 3
- TPSA
- 103 Ų
- H-bond donors
- 3
- H-bond acceptors
- 8
- Rotatable bonds
- 6
- Heavy atoms
- 31
SMILES C1CN(C[C@@H]1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4
Computed descriptors from PubChem (CID 72165228), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il